Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

Abstract The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease) is a two-arm, multi-centre, randomised controlled trial being run in India and Australia that investigates the effectiveness of angiotensin receptor blockers in addition to standard c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	J. M. McGree, C. Hockham, S. Kotwal, A. Wilcox, A. Bassi, C. Pollock, L. M. Burrell, T. Snelling, V. Jha, M. Jardine, M. Jones, for the CLARITY Trial Steering Committee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-04-01
Colecção:	Trials
Assuntos:	Adaptive sample size Angiotensin receptor blockers Bayesian design Clinical trial Coronavirus Protocol
Acesso em linha:	https://doi.org/10.1186/s13063-022-06167-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!